Questionnaire
Otherconventional intra-oral examination and questionnaire
Other names: intra-oral examination
NCT Number: NCT04540250
This study included rheumatoid arthritis patients receiving Methotrexate as monotherapy. All eligible patients were subjected to thorough clinical examination and full history to identify oral events. Drug history, current dose and duration of MTX were recorded.
Looking for future studies?
Notify MeAll sexes
Observational
The current study was conducted in the Clinics of Oral Medicine, Faculty of Dentistry and Rheumatology, Faculty of Medicine - Cairo University from 2017 to 2019. This study followed the principles of the Helsinki Declaration and was approved by the Research ethics committee of Faculty of Dentistry, Cairo University.
RA patients receiving MTX as monotherapy were included in the study. Patients suffering from systemic disease known to cause oral manifestations; salivary gland diseases and malignancies were excluded.
All eligible patients were subjected to thorough clinical examination for the whole oral cavity. Medical history and history of any oral manifestation were recorded. Drug history, dose, and duration of MTX were recorded.
Categorical data was presented as frequencies and percentages. Continuous data was described as means and standard deviations. Means were compared by one-way ANNOVA and Student-t-test. The significance level was set at P ≤0.05. Statistical analysis was performed with IBM® SPSS® Statistics Version 25 for Windows.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
conventional intra-oral examination and questionnaire
Other names: intra-oral examination
Time frame: throughout the study time (one year)
Clinical examination (intra-oral) and history of oral mucositis where recorded
Beni-Suef University
Other
Stratification of Oral Lesions in Methotrexate-treated Rheumatoid Arthritis Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07094880
Advantage of Using Subcutaneous Route for Methotrexate, Arthritis
View Trial DetailsNCT02011022
Hematologic Diseases, Hemic and Lymphatic Diseases
Hangzhou, Zhejiang, China
View Trial DetailsNCT06641128
Arthritis, Arthritis, Rheumatoid
Al Mansurah, Egypt
View Trial DetailsNCT07724444
Mouth Diseases, Neurologic Manifestations
Pavia, Lombardy, Italy
View Trial Details